Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2014-03-12
AEs
2
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2014-03-18 (study day 7.0); relationship: REMOTE
mild
assessed
Mild HYPERHIDROSIS — outcome: RECOVERED/RESOLVED; onset 2014-03-18 (study day 7.0); relationship: REMOTE
Data queries
No data queries.